Exagen to announce fourth quarter 2023 and full-year financial results on march 18, 2024

Carlsbad, calif., march 07, 2024 (globe newswire) -- exagen inc. (nasdaq: xgn), a leading provider of autoimmune testing, will release financial results for the quarter and year ended december 31, 2023, before the market opens on monday, march 18, 2024. john aballi, exagen's president and chief executive officer, and kamal adawi, chief financial officer, will host a conference call to review the company's results at 8:30 am et (5:30 am pt).
XGN Ratings Summary
XGN Quant Ranking